Baird Financial Group, Inc. Grifols Sa Transaction History
Baird Financial Group, Inc.
- $50.4 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding GRFS
# of Institutions
170Shares Held
145MCall Options Held
166KPut Options Held
103K-
Capital World Investors Los Angeles, CA21.1MShares$150 Million0.02% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA20.5MShares$146 Million1.82% of portfolio
-
Permian Investment Partners, LP New York, NY16.2MShares$115 Million21.69% of portfolio
-
Black Creek Investment Management Inc. Toronto, A611.3MShares$80 Million3.99% of portfolio
-
Armistice Capital, LLC New York, NY10MShares$71.4 Million1.05% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $4.83B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...